Effect of UVA1 on hypertrophic scarring in the rabbit ear model

Biosci Rep. 2020 Jan 31;40(1):BSR20190007. doi: 10.1042/BSR20190007.

Abstract

Hypertrophic scars (HTSs) are common and cause functional and psychological morbidity. UVA1 (340-400 nm) phototherapy has been previously shown to be effective in the treatment of localized scleroderma, systemic sclerosis, and POEMS syndrome with minimal side effects, all of which are presented as collagen fibrils hyperplasia that is common with scarring in skin histology. In the present study, we aimed to investigate the impact of UVA1 on the protein expression of TGF-β signal pathway and myofibroblasts in a rabbit model of cutaneous scarring. Full-thickness skin wounds (2 cm × 5 cm in diameter) were made in New Zealand white rabbits to establish the hypertrophic scarring model. New Zealand white rabbits were divided into two treatment groups (n=30 wounds per group with an equal number of controls): medium-dose of UVA1 phototherapy group: 60 J/cm2; high-dose of UVA1 phototherapy group: 110 J/cm2. Left ears were used for treatment and the right ones were used for control. Treatment was administered five times weekly for 6 weeks. Treated and untreated control wounds were harvested at various time points and examined by histologic examination, immunohistochemical assessment, and ultrastructural evaluation. The results showed that UVA1 phototherapy caused a significant reduction in dermal thickness by histological features, whereas the scar index was descended significantly in both medium- and high-dose UVA1 groups compared with the control group. Examination of immunohistochemistry also revealed a marked suppression of tissue growth factor-β (TGF-β) (both medium- and high-dose), α smooth muscle actin (α-SMA) (only high-dose), and tissue inhibitor of metalloproteinase 1 (TIMP-1) (only high-dose), and apparent increase in matrix metalloproteinases (MMP-1) (both medium- and high-dose) compared with the control. The ultrastructural evaluation showed the collagen fibers' diameter had shrunk, and that fibroblastic cytoplasm was not affluent and in a quiescent stage. These findings of the present study suggested that administration of UVA1 irradiation is effective to improve the experimental HTS model and raises a possibility of the therapeutic approach of UVA1 in the scar. Although not directly examined in the present study, MMP inhibition is hypothesized to be responsible for this effect. However, early UVA1 treatment could not prevent the formation of scar model.

Keywords: Hypertrophic scar; Matrix metalloproteinase-1; Rabbit model; Tissue growth factor-β; Ultraviolet A1; a-smooth muscle actin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Actins / metabolism
  • Animals
  • Cicatrix, Hypertrophic / metabolism
  • Cicatrix, Hypertrophic / pathology
  • Cicatrix, Hypertrophic / radiotherapy*
  • Collagen / metabolism
  • Disease Models, Animal
  • Female
  • Matrix Metalloproteinase 1 / metabolism
  • Myofibroblasts / metabolism
  • Myofibroblasts / radiation effects*
  • Myofibroblasts / ultrastructure
  • Rabbits
  • Skin / metabolism
  • Skin / radiation effects*
  • Skin / ultrastructure
  • Tissue Inhibitor of Metalloproteinase-1 / metabolism
  • Transforming Growth Factor beta / metabolism
  • Ultraviolet Therapy*

Substances

  • Actins
  • Tissue Inhibitor of Metalloproteinase-1
  • Transforming Growth Factor beta
  • Collagen
  • Matrix Metalloproteinase 1